Managed Care Considerations for Chronic Cough
An American Journal of Managed Care® Supplement
This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp.
Faculty
Desola Davis, PharmD, BCPS, BCACP
Drug Use Management Clinical Pharmacy Specialist
Kaiser Permanente Georgia
Atlanta, Georgia
Peter Dicpinigaitis, MD
Professor of Medicine
Albert Einstein College of Medicine
Director, Montefiore Cough Center
Montefiore Medical Center
Bronx, New York
Phung C. On, PharmD, BCPS
Assistant Professor of Pharmacy Practice
School of Pharmacy – MCPHS University School of Pharmacy – Boston
Clinical Pharmacy Specialist – Transitions of Care
Boston Health Care for the Homeless Program
Boston, Massachusetts
Medical Writing and Editorial Support
Debra Gordon, MS
President
GordonSquared, Inc
Highland Park, Ilinois
Brittany Hoffmann-Eubanks, PharmD, MBA
Owner
Banner Medical, LLC
Frankfort, Illinois
C. Andrew Kistler, MD, PharmD
Clinical Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Thomas Jefferson University Hospital
Sidney Kimmel Medical College
Philadelphia, Pennsylvania
Program Description
Activity Overview
Chronic cough is the most common symptom for which individuals seek medical advice. This health issue has a substantial impact on a person’s quality of life and can produce complications such as vomiting, fractures, muscle pain, syncope, and depression. Pharmacists and managed care professionals should recognize the complicated etiology of chronic cough and its difficult management. As there are currently no available therapies specifically indicated for this, the emerging treatment options that are targeted for patients with chronic cough have the promising potential to fulfill unmet needs in this population. They will resolve or minimize the significant burden on healthcare resources, families, work, and school, and improve patients’ overall health.
Statement of Educational Need
Chronic cough is a highly debilitating condition that can result from multiple etiologies or is sometimes due to unknown causes. Further, there are no FDA-approved agents at this time that specifically address chronic cough. Combined with a lack of robust efficacy for agents used to treat acute cough, there is a significant unmet need for efficacious agents that provide relief for patients with chronic cough. To address these concerns, new agents with novel mechanisms of action are in development and, if found safe and effective, could become available in the United States. Therefore, healthcare professionals require continuing professional education and application of this knowledge to improve chronic cough management, clinical decision making, and the quality of life among patients affected.
Target audience: Managed care pharmacists
Activity type: Application
Release date: October 15, 2020
Expiration date: October 15, 2021
Estimated time to complete activity: 3.0 hours
Fee: Free
Educational Objectives
At the completion of this activity, the participant will be able to:
- Examine the etiologies of chronic cough, the burden, and the pathophysiology.
- Explain the treatment options for chronic cough including the emerging therapies.
- Identify opportunities to improve the management of chronic cough from a payer and patient perspective, as well as to integrate new treatments into the existing treatment algorithm.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.3 CEU) under the ACPE universal activity number 0290-0000-20-214-H01-P. The activity is available for CE credit through October 15, 2021.This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education™. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this journal-based CME activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 3.0 Contact Hours.
Physicians and Nurses seeking credit should visit: https://www.gotoper.com/online-cme-activities/online-activities/chroniccough2020 to participate in this activity.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the online article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Peter Dicpinigaitis, MD, has the following relevant financial relationships with commercial interests to disclose:
- Consultant - Bayer HealthCare Pharmaceuticals, Bellus Health Inc, Merck Sharp & Dohme Corp, Shionogi
Editorial Support Disclosures
Brittany Hoffmann-Eubanks, PharmD, MBA, and C. Andrew Kistler, MD, PharmD, have no relevant financial relationships with commercial interests to disclose.
Debra Gordon, MS, has the following relevant financial relationships with commercial interests to disclose:
- Stockholder - Merck Sharp & Dohme Corp, AbbVie
- Spouse Employed by AbbVie
Planning Staff: Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Ann Marciano; Brianna Schauer, MBA; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.
Physicians’ Education Resource®, LLC
Planning Staff: The staff of Physicians’ Education Resource®, LLC has no relevant financial relationships with commercial interests to disclose.
Anonymous peer reviewers were part of the content validation and conflict resolution and have no relevant financial relationships with commercial interests to disclose.
Disclosure Policy
According to the disclosure policy of The American Journal of Managed Care® and Pharmacy Times Continuing Education™, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education™ to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
Disclosure of Unapproved/Off-Label Use
The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and they are advised to consult prescribing information for these products.
The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care®, Pharmacy Times Continuing Education™, or any of the companies that provided commercial support for this CE activity.
Signed disclosures are on file at the office of The American Journal of Managed Care®, Cranbury, New Jersey.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
